Quarterly report pursuant to Section 13 or 15(d)

Long-Term Debt and Other Financings (Tables)

v3.3.0.814
Long-Term Debt and Other Financings (Tables)
9 Months Ended
Sep. 30, 2015
Debt Disclosure [Abstract]  
Aggregate future principal and final fee payments of interest bearing obligations

Aggregate future principal, final payment fees and discounts of the Company’s total interest bearing obligations - long-term as of September 30, 2015, are as follows (in thousands):

 

Three months ending December 31, 2015

 

$

475

 

Year ended 2016

 

 

9,149

 

Year ended 2017

 

 

14,852

 

Year ended 2018

 

 

18,117

 

Year ended 2019

 

 

 

Year ended 2020

 

 

15,394

 

 

 

 

57,987

 

Less: Interest, final payment fee, discount and issuance cost

 

 

(9,402

)

 

 

 

48,585

 

Less: current portion

 

 

(4,123

)

 

 

$

44,462

 

 

Interest expense and amortization of debt issuance costs

Amortization of debt issuance costs and discounts are included in interest expense. Interest expense in the condensed consolidated statements of comprehensive loss for the three and nine months ended September 30, 2015 and 2014, relates to the following debt instruments (in thousands):

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2015

 

 

2014

 

 

2015

 

 

2014

 

Hercules loan

 

$

665

 

 

$

 

 

$

1,551

 

 

$

 

Servier loan

 

 

278

 

 

 

583

 

 

 

806

 

 

 

1,770

 

GECC term loan

 

 

 

 

 

398

 

 

 

548

 

 

 

1,268

 

Novartis note

 

 

84

 

 

 

79

 

 

 

243

 

 

 

234

 

Other

 

 

3

 

 

 

 

 

 

4

 

 

 

23

 

Total interest expense

 

$

1,030

 

 

$

1,060

 

 

$

3,152

 

 

$

3,295